Cannabis industry developments lead today’s news, with an escalating takeover battle, record financial results and a significant California safety investigation. Together, the stories highlight the sector’s increasingly consequential questions around consolidation, operating scale and regulatory oversight.
Curaleaf Asks Regulator to Halt Aurora Share Sales During Hostile Bid
Curaleaf Holdings filed an application with the Alberta Securities Commission on September 14 seeking to stop Aurora Cannabis from issuing additional shares through its at-the-market equity program while Curaleaf’s unsolicited takeover offer remains outstanding.
Curaleaf alleges that Aurora issued approximately 2.81 million shares at an average price of US$3.04 after Curaleaf first expressed interest in a transaction, increasing the cost of its offer by more than US$11 million. The bidder characterized the issuances as an improper defensive tactic and said the program has diluted Aurora shareholders by approximately 10.8% since it was established in February.
Aurora responded that the program was disclosed months before the hostile bid, has been inactive for several weeks and was designed to fund acquisitions and cultivation capacity. Aurora’s board continues to recommend that shareholders reject Curaleaf’s offer, and no decision from the securities commission had been reported.
Why It Matters: Analysis: A regulatory order restricting Aurora’s financing options could alter both the cost and mechanics of the takeover. The proceeding could also clarify how Canadian regulators view equity issuance programs used by a company while it is defending against a hostile bid.
Source: Curaleaf Holdings
High Tide Reports Record Revenue and Profitability
High Tide reported record revenue of C$198.8 million for its fiscal third quarter ended July 31, an increase of 33% from the same period last year. Adjusted EBITDA rose 53% to C$16.2 million, while the cannabis retailer reported C$12.7 million in net income and C$7 million in free cash flow.
The company’s Canna Cabana chain reached 232 Canadian locations and held a reported 14% share of the cannabis retail market in the provinces where it operates, excluding British Columbia. Its German medical cannabis subsidiary, Remexian, distributed a record 10.2 tonnes during the quarter and generated C$38.2 million in revenue.
Why It Matters: Analysis: The results demonstrate operating leverage at one of Canada’s largest cannabis retailers while showing how international medical cannabis can provide a second growth engine. Sustained cash generation could also give High Tide greater flexibility to open stores, pursue acquisitions and respond to future U.S. market opportunities.
Source: High Tide Inc.
California Suspends Major Cannabis Grow and Traces Recalled Product
California cannabis regulators suspended commercial activity at a large licensed cultivation operation following the unexplained death of a worker and the discovery of alleged pesticide, inventory and track-and-trace violations. Authorities executing a search warrant reported finding 55,069 cannabis plants, approximately 6,000 pounds of processed cannabis, unidentified illegal chemicals and about 20,000 gallons of contaminated liquid requiring specialized disposal.
The Department of Cannabis Control said potentially contaminated material transferred from the cultivator was identified through the state’s tracking system and either recalled or placed under embargo. A recall notice covered three batches of Natura Manufacturing’s Iced Infused Flower that regulators said were produced with material cultivated under conditions that did not conform with pesticide requirements.
No causal connection has been established between the worker’s death and possible chemical exposure, and no arrests were reported. The investigation remains active.
Why It Matters: Analysis: The case is a major test of California’s ability to monitor large licensed grows and trace questionable material after it enters the commercial supply chain. Any expansion of the recall or evidence of systemic compliance failures could affect manufacturers, retailers and consumer confidence beyond the cultivation site itself.
Source: MJBizDaily
What We’re Watching
Over the next 24 to 72 hours, watch for an Alberta Securities Commission response to Curaleaf’s request, additional guidance from High Tide’s earnings webcast and any California regulatory or law-enforcement updates concerning the suspended cultivation operation, the worker’s cause of death or the scope of affected products.
